Strauss Borrelli PLLC, a leading data breach law firm, is investigating Acorda Therapeutics, Inc., regarding its recent breach. The Acorda Therapeutics data breach involved sensitive personal identifiable information belonging to over 1,500 individuals.
ABOUT ACORDA THERAPEUTICS, INC.:
Acorda Therapeutics is a publicly traded biotechnology company that develops commercial neurological therapies. Acorda Therapeutics started as a network of physicians, scientists, and businesspeople in 1995. With locations in Ardsley and Chelsea, New York, Acorda Therapeutics has over 500 employees.
WHAT HAPPENED?
On or about January 18, 2022, Acorda Therapeutics discovered that it had experienced a data breach in which the sensitive personal identifiable information in its system may have been accessed. On May 27, 2022, Acorda Therapeutics began notifying individuals whose information may have been impacted. The type of information exposed includes:
- Name
- Social Security number
If you have provided your personal information to Acorda Therapeutics, Inc.:
We would like to speak with you about your rights and potential legal remedies in response to this data breach. Please fill out the form, below, or contact us at 872.263.1100 or sam@straussborrelli.com.
